SMFM and the Preeclampsia Foundation to host President’s Workshop on Preeclampsia
The Society for Maternal-Fetal Medicine (SMFM) will partner with the Preeclampsia Foundation to host the President’s Workshop on Preeclampsia during SMFM’s 41st Annual Pregnancy Meeting, being held virtually today through Saturday.
The Society for Maternal-Fetal Medicine (SMFM) will partner with the Preeclampsia Foundation to host the President’s Workshop on Preeclampsia from Jan. 25-26. This two-day workshop will offer an in-depth look at how practitioners can predict, prevent, and manage preeclampsia in pregnancy.
The workshop will cover a wide range of relevant topics, including how to better determine at-risk mothers, implications on future cardiovascular health, impacts on long-term mental health, and more. Spreading awareness is crucial, says Preeclampsia Foundation CEO Eleni Z. Tsigas, because many preeclampsia symptoms can occur during a healthy pregnancy which can cause them to be overlooked.
The partnering organizations will also host a Twitter chat, “Let’s Talk about Pregnancy Complications,” with the parenting website BabyCenter, on Jan. 26 at 3 p.m. EST. Women will share personal stories to help spread awareness of preeclampsia and advocate critical warning signs.
For additional coverage of SMFM’s 2021 Virtual Annual Meeting, visit our Conference Coverage page. Interested participants can register for the conference via this link.
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
